These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22819085)

  • 1. Disease activity assessment and patient-reported outcomes in patients with early rheumatoid arthritis.
    Sokka T; Rannio T; Khan NA
    Rheum Dis Clin North Am; 2012 May; 38(2):299-310. PubMed ID: 22819085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should rheumatoid arthritis disease activity be measured today and in the future in clinical care?
    Sokka T
    Rheum Dis Clin North Am; 2010 May; 36(2):243-57. PubMed ID: 20510232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight disease control in early RA.
    Sen D; Brasington R
    Rheum Dis Clin North Am; 2012 May; 38(2):327-43. PubMed ID: 22819087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging applications in early rheumatoid arthritis diagnosis and management.
    Troum OM; Pimienta O; Olech E
    Rheum Dis Clin North Am; 2012 May; 38(2):277-97. PubMed ID: 22819084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial management of rheumatoid arthritis.
    Gramling A; O'Dell JR
    Rheum Dis Clin North Am; 2012 May; 38(2):311-25. PubMed ID: 22819086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria.
    Kuriya B; Sun Y; Boire G; Haraoui B; Hitchon C; Pope JE; Thorne JC; Keystone EC; Bykerk VP;
    J Rheumatol; 2012 Jun; 39(6):1155-8. PubMed ID: 22505708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of control of rheumatoid arthritis disease activity.
    Salomon-Escoto KI; Gravallese EM; Kay J
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):497-507. PubMed ID: 22137920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and the outcome of established rheumatoid arthritis.
    Kingsley G; Scott IC; Scott DL
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):585-606. PubMed ID: 22137926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis.
    Katchamart W; Bombardier C
    J Rheumatol; 2010 Jul; 37(7):1411-5. PubMed ID: 20436069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice.
    Masri KR; Shaver TS; Shahouri SH; Wang S; Anderson JD; Busch RE; Michaud K; Mikuls TR; Caplan L; Wolfe F
    J Rheumatol; 2012 Jun; 39(6):1139-45. PubMed ID: 22589262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving tight control in rheumatoid arthritis.
    van Hulst LT; Hulscher ME; van Riel PL
    Rheumatology (Oxford); 2011 Oct; 50(10):1729-31. PubMed ID: 21933791
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving the routine management of rheumatoid arthritis: the value of tight control.
    Mease PJ
    J Rheumatol; 2010 Aug; 37(8):1570-8. PubMed ID: 20595287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index.
    Aletaha D; Martinez-Avila J; Kvien TK; Smolen JS
    Ann Rheum Dis; 2012 Jul; 71(7):1190-6. PubMed ID: 22454398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proposed 30-45 minute 4 page standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes.
    Pincus T; Brooks RH; Callahan LF
    J Rheumatol; 1999 Feb; 26(2):473-80. PubMed ID: 9972990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established rheumatoid arthritis: clinical assessments.
    van Riel PL; Fransen J
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):807-25. PubMed ID: 17870029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data.
    Yazici Y; Kautiainen H; Sokka T
    J Rheumatol; 2007 Feb; 34(2):311-5. PubMed ID: 17304656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging in rheumatoid arthritis.
    Tan YK; Conaghan PG
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):569-84. PubMed ID: 22137925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
    Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J
    J Rheumatol; 2012 Jun; 39(6):1171-8. PubMed ID: 22505700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.